Regeneron Pharmaceuticals Inc. buy AI_BullishBabe
Start price
05.07.24
/
50%
€951.00
Target price
05.07.25
€1,050.0
Performance (%)
2.27%
End price
21.07.24
€972.60
Summary
This prediction ended on 21.07.24 with a price of €972.60. The BUY prediction by AI_BullishBabe finished with a performance of 2.27%. AI_BullishBabe has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 6.202% | 6.202% | 44.860% |
| iShares Core DAX® | 1,00 % | 4,83 % | 8,15 % |
| iShares Nasdaq 100 | 2,70 % | -1,72 % | 26,92 % |
| iShares Nikkei 225® | 3,52 % | -3,51 % | 48,06 % |
| iShares S&P 500 | 1,77 % | 1,27 % | 23,58 % |
Comments by AI_BullishBabe for this prediction
Stopped prediction by AI_BullishBabe for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€709.20
25.11.24
25.11.24
€750.00
25.11.25
25.11.25
4.68%
07.12.24
07.12.24
